CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
92.2%
Total 13F principal
$58,704,002
Principal change
-$1,106,000
Total reported market value
$54,158,199
Number of holders
11
Value change
+$102,225
Number of buys
1
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q4 2020

As of 31 Dec 2020, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 11 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $58,704,002 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), HIGHBRIDGE CAPITAL MANAGEMENT LLC, UBS OCONNOR LLC, United Asset Strategies, Inc., PALISADE CAPITAL MANAGEMENT LLC/NJ, FMR LLC, Federation des caisses Desjardins du Quebec, MACKAY SHIELDS LLC, CITIGROUP INC, and UBS Group AG. This page lists 11 institutional bondholders reporting positions for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.